OrBec beclomethasone dipropionate: Phase III started

Soligenix (formerly Dor BioPharma Inc.) began the double-blind, placebo-controlled U.S. Phase III SUPPORTS trial to evaluate oral orBec given twice daily for 50 days. Soligenix has an SPA from FDA fo...